MYC and B-cell non-Hodgkin lymphoma: In this setting, expression of the Myc oncogene under the control of the enhancer of IgH (Eμ-Myc) in the B-cell lineage drives a lethal lymphoma, similar to B-cell lymphomas, with a median survival of only 4 months.